— Know what they know.
Not Investment Advice
Also trades as: COX.PA (PAR) · $vol 0M · ALCOX.PA (PAR) · $vol 0M

NICXF OTC

Nicox S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -83.0% 5Y: -93.8%
$0.30
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $29.2M mcap · 93M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$24M -53.9% ▼
Total Liabilities
$21M -33.4% ▼
5Y CAGR: +6.3%
Shareholders Equity
$3M -84.1% ▼
Cash & Investments
$11M -6.4% ▼
Total Debt
$18M -29.5% ▼
Net Debt
$7M -48.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$47M$42M$27M$11M$11M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$47M$42M$27M$11M$11M
Net Receivables$2M$1M$40M$38M$10M
Inventory$0$0$0$0$0
Other Current Assets$894K$2M$2M$1M$2M
Total Current Assets$53M$48M$71M$51M$24M
Property, Plant & Equip.$1M$1M$25K$26K$11K
Goodwill & Intangibles$89M$66M$27M$24K$13K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$68K$237K-$22M$2M$725K
Total Non-Current Assets$90M$67M$5M$2M$749K
Total Assets$142M$115M$76M$53M$24M
— Liabilities —
Accounts Payable$2M$4M$3M$2M$2M
Short-Term Debt$5M-$4M$496K$25M$585K
Deferred Revenue$7M$4M$2M$0$0
Other Current Liabilities-$2M$2M-$879K-$23M$735K
Total Current Liabilities$15M$8M$8M$6M$4M
Long-Term Debt$13M$21M$25M$25M$15M
Other Non-Current Liab.$13M$661K-$7M$713K$281K
Total Non-Current Liabilities$26M$31M$26M$27M$17M
Total Liabilities$41M$39M$34M$32M$21M
— Equity —
Common Stock$37M$43M$50M$50M$692K
Retained Earnings-$18M-$44M-$537M-$558M-$531M
Accumulated OCI-$446M-$459M$0$0$0
Total Stockholders Equity$101M$76M$42M$21M$3M
Total Liabilities & Equity$142M$115M$93M$53M$24M
— Key Metrics —
Total Debt$19M$22M$27M$25M$18M
Net Debt-$28M-$20M-$569K$14M$7M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms